SONIA GODBOLE: Open Payments
NPI 1689752701 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 11 payments from 10 companies in 2025. Trend: 2023 $16 · 2024 $215 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $108 |
| Noven Therapeutics, LLC | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Corium, LLC | 1 | $26 |
| ABBVIE INC. | 1 | $25 |
| Lundbeck LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Vertical Pharmaceuticals, LLC | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
Products named: REXULTI, Xelstrym, FANAPT, CAPLYTA, Azstarys, VRAYLAR, TRINTELLIX, Relexxii.
Industry payments across AZ — which companies pay providers there.
